跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SKIIP - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SKIIP
Approved
STANDARD
SKIIP
Rubicon Research Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3dcc193ee630f3cc
Company
Rubicon Research Private Limited
Type
Standard
Approval Details
Approval Id
3dcc193ee630f3cc
Drug Approval Philippines Name
SKIIP
Product Name
SKIIP
Registration Number
DR-XY49354
Brand Name
SKIIP
Generic Name
Nicotine
Dosage Form
Lozenges (Cherry Flavor)
Dosage Strength
2 mg (equivalent to 10 mg nicotine polacrilex)
Manufacturer
Rubicon Research Private Limited
Importer
Buergli Pharma Inc.
Distributor
Buergli Pharma Inc.
Company Detail Path
/organization/rubicon-research-private-limited
Issuance Date
14 April 2025
Expiry Date
14 April 2030
Pharmacologic Category
Drug used in nicotine dependence
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3dcc193ee630f3cc
Type
Standard
Back to Philippines FDA Approvals